Folic acid in obstetric practice: A review

Obstetrical and Gynecological Survey

Volumn 66, Issue 4, 2011, Pages 240-247

  Talaulikar, Vikram Sinai ^a   Arulkumaran, Sabaratnam ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

CANCER RISK; CLINICAL PRACTICE; COLORECTAL ADENOMA; COLORECTAL CANCER; DIABETES MELLITUS; EPILEPSY; FOLIC ACID DEFICIENCY; FOOD INTAKE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HUMAN; MEGALOBLASTIC ANEMIA; META ANALYSIS (TOPIC); NEURAL TUBE DEFECT; OBESITY; OBSTETRIC CARE; REVIEW; RISK FACTOR; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

ADENOMA; ANIMALS; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; PRENATAL CARE;

EID: 79961071065     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e318223614c     Document Type: Review

References (56)

1. De-Regil LM, Ferná ndez-Gaxiola AC, Dowswell T, et al. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2010:CD007950.
2. Obican SG, Finnell RH, Mills JL, et al. Folic acid in early pregnancy: a public health success story. FASEB J. 2010;24: 4167-4174.
3. Wills L. Treatment of pernicious anaemia of pregnancy and tropical anaemia with special reference to yeast extract as curative agent. Br Med J. 1931;1:1059-1064.
4. Mitchell HK, Snell EE, Williams RJ. The concentration of folic acid. J Am Chem Soc. 1941;63:2284.
5. US Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule. 21 CFR Parts 136, 137, and 139. Fed Regist. 1996;61:8781-8780.
6. US Department of Agriculture, Agricultural Research Service. 2003. USDA National Nutrient Database for Standard Refer-ence, Release 16. Nutrient Data Laboratory Home Page. Available at: http://www.nal.usda.gov/fnic/cgi-bin/nut- search.pl.
7. Molloy AM, Daly S, Mills JL, et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet. 1997;349:1591-1593. (Pubitemid 27229139)
8. Board Recommends Mandatory Fortification, Food Standards Agency. May 2007. Available at: http://www.food.gov.uk/news/newsarchive/2007/may/folatefort.
9. Martí-Carvajal A, Peñ a-Martí G, Comuniá n-Carrasco G, et al. Prematurity and maternal folate deficiency: anemia during pregnancy study group results in Valencia, Venezuela. Arch Latinoam Nutr. 2004;54:45-49.
10. Nilsen RM, Vollset SE, Rasmussen SA, et al. Folic acid and multivitamin supplement use and risk of placental abruption: a population-based registry study. Am J Epidemiol. 2008;167: 867-874. (Pubitemid 351451743)
11. Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr. 2000;71(suppl 5):1295S-1303S. (Pubitemid 30230532)
12. Ananth CV, Peltier MR, Moore DF, et al; New Jersey-Placental Abruption Study Investigators. Reduced folate carrier 80A-+G polymorphism, plasma folate, and risk of placental abruption. Hum Genet. 2008;124:137-145.
13. Ananth CV, Peltier MR, De Marco C, et al; New Jersey-Placental Abruption Study Investigators. Associations between 2 polymorphisms in the methylenetetrahydrofolate reductase gene and placental abruption. Am J Obstet Gynecol. 2007;197:385.e1-385.e7.
14. Cragan JD, Roberts HE, Edmonds LD, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis-United States, 1985-1994. Mor Mortal Wkly Rep. 1995;44:1-13.
15. Shibuya K, Murray CJ. Congenital anomalies. In: Murray CJ, Lopez AD, eds. Health Dimensions of Sex and Reproduction: the Global Burden of Sexually Transmitted Diseases, HIV, Maternal Conditions, Perinatal Disorders, and Congenital Anomalies. Vol 3. Boston, MA: Harvard University Press, 1998:455-512.
16. Maldonado E, Murillo J, Barrio C, et al. Occurrence of cleft-palate and alteration of Tgf-(3) expression and the mechanisms leading to palatal fusion in mice following dietary folic-acid deficiency. Cells Tissues Organs. In press.
17. Salerno P, Bianchi F, Pierini A, et al. Folic acid and congenital malformation: scientific evidence and public health strategies [in Italian]. Ann Ig. 2008;20:519-530.
18. Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev. 2008: CD004514.
19. Kronenberg G, Colla M, Endres M. Folic acid, neurodegenerative and neuropsychiatric disease. Curr Mol Med. 2009;9: 315-323.
20. Stanger O, Fowler B, Piertzik K, et al. Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother. 2009;9: 1393-1412.
21. Voutilainen S, Rissanen TH, Virtanen J, et al. Low dietary folate intake is associated with an excess incidence of acute coronary events: the kuopio ischemic heart disease risk factor study. Circulation. 2001;103:2674-2680. (Pubitemid 32538781)
22. Doshi SN, McDowell IF, Moat SJ, et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine. Circulation. 2002;105:22-26. (Pubitemid 34049137)
23. Doshi SN, McDowell IF, Moat SJ, et al. Folate improves endothelial function in coronary artery disease. Arterioscler Thromb Vasc Biol. 2001;21:1196-1202.
24. Wald DS, Bishop L, Wald NJ, et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med. 2001;161:695-700. (Pubitemid 32200221)
25. Clarke R, Halsey J, Lewington S, et al; B-Vitamin Treatment Trialists' Collaboration. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med. 2010;170:1622-1631.
26. Herbert V. Folic Acid. In: Shils M, Olson J, Shike M, et al, eds. Nutrition in Health and Disease. Baltimore, MD: Williams & Wilkins, 1999.
27. Mills JL, Von Kohorn I, Conley MR, et al. Low vitamin B-12 concentrations in patients without anemia: the effect of folic acid fortification of grain. Am J Clin Nutr. 2003;77:1474-1477. (Pubitemid 39655282)
28. Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003;133:3731S-3739S.
29. Song J, Medline A, Mason JB, et al. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res. 2000;60:5434-5440.
30. Song J, Sohn KJ, Medline A, et al. Chemopreventive effects of dietary folate on intestinal polyps in Apc/2Msh22/2 mice. Cancer Res. 2000;60:3191-3199. (Pubitemid 30407916)
31. Mason JB, Aaron D, Jacques PF, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2007; 16:1325-1329. (Pubitemid 47076861)
32. Kim YI. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev. 2004;13:511-519.
33. McCullough ML, Giovannucci EL. Diet and cancer prevention. Oncogene. 2004;23:6349-6364. (Pubitemid 39265504)
34. Crott J, Mason JB. MTHFR polymorphisms and colorectal neoplasia. In: Ueland P, Rozen R, eds. MTHFR Polymorphisms and Disease. Georgetown, TX: Landes Bioscience, 2005:179-184.
35. Choi S-W, Mason JB. Folate status: effects on pathways to colorectal carcinogenesis. J Nutr. 2002;132:2413S-2418S. (Pubitemid 34848118)
36. Farber S. Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood. 1949;4:160-167.
37. Heinle RW, Welch AD. Experiments with pteroylglutamic acid and pteroylglutamic acid deficiency in human leukemia [abstract]. J Clin Invest. 1948;27:539.
38. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas. JAMA. 2007;297:2351-2359.
39. Mason JB, Cole BF, Baron JA, et al. Folic acid fortification and cancer risk. Lancet. 2008;371:1335; author reply 1335-1336.
40. Fife J, Raniga S, Hider PN, et al. Folic acid supplementation and colorectal cancer risk: a meta-analysis. Colorectal Dis. 2011;13:132-137.
41. Kennedy DA, Stern SJ, Matok I, et al. Folate intake and the risk of colorectal cancer: a systematic review and metaanalysis. Cancer Epidemiol. 2011;35:2-10.
42. Kim DH, Smith-Warner SA, Spiegelman D, et al. Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control. 2010;21:1919-1930.
43. Jung Eun Lee, Walter C Willett, Charles S Fuchs, et al. Folate intake and risk of colorectal cancer and adenoma: modification by time. Am J Clin Nutr. 2011;93:817-825.
44. Young-In Kim. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr. 2004;80:1123-1128.
45. Hibbard BM. The role of folic acid in pregnancy with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw. 1964;71;529-542.
46. Lumley J, Watson L, Watson M, et al. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2001: CD001056.
47. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, et al. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One. 2009;4:e7845.
48. Finnell R, Shaw G, Lammer E, et al. Gene-nutrient interactions: importance of folates and retinoids during early embryogenesis. Toxicol Appl Pharmacol. 2004;198:75-85. (Pubitemid 38952829)
49. Wald NJ, Law MR, Morris JK, et al. Quantifying the effect of folic acid. Lancet. 2001;358:2069-2073. (Pubitemid 34084836)
50. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-137.
51. Rasmussen SA, Chu SY, Kim SY, et al. Maternal obesity and risk of neural tube defects: a meta-analysis. Am J Obstet Gynecol. 2008;198:611-619. (Pubitemid 351758926)
52. Mojtabai R. Body mass index and serum folate in childbearing age women. Eur J Epidemiol. 2004;19:1029.
53. Ray Joel G, Wyatt Philip R, Vermeulen Marian J, et al. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynecol. 2005;105:261-265.
54. CMACE/RCOG Joint Guideline: Management of Women with Obesity in Pregnancy: CMACE/RCOG, Centre for Maternal and Child Enquiries and Royal College of Obstetricians and Gynaecologist, UK. March 2010.
55. Tam C, McKenna K, Ingrid Goh Y, et al. Periconceptional folic acid supplementation: a new indication for therapeutic drug monitoring. Ther Drug Monit. 2009;31:319-326.
56. Daly LE, Kirke PN, Molloy A, et al. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995;274:1698-1702.